Re:Cell

Advanced VSELs Therapy

Safest Pluripotent Regeneration World-class

Re:Cell is an advanced autologous stem cell protocol utilizing Very Small Embryonic-Like Stem Cells (VSELs) designed to support cellular repair, regeneration, and long-term biological function.

Cells are derived from the patient’s own blood and processed under controlled clinical standards—ensuring safety, compatibility, and integrity.

No genetic modification. No shortcuts.

Clinical Advantages

Physician-Guide Protocol

Prescribed by clinical indication-after screening and physician review. No trend logic. No shortcuts.

Controlled Processing

Protocol-driven, autologous source without genetic modification.

Monitored Outcomes

Monitored plan with structured follow-up to assess response over time

At FS RÉGENÈRA, credibility defines every protocol

In partnership with world-renowned scientific experts, we bring German-engineered regenerative science to Indonesia—delivered through precise, internationally aligned clinical protocols.

Ideal Candidates for Re:Cell

Indicated for individuals 35+ experiencing early decline in cellular performance, skin quality, recovery capacity, and menopause.

Age 35 & Older

Declining Skin Vitality

Symptoms of Menopause

For Those Seeking

Preventive Cellular Protocol - Highest Safety Profile

Initiate Cellular Regeneration - Proactive Rejuvenation

Observed Clinical Outcomes

Improved Skin Elasticity

Enhanced Cellular Function

Increased Vitality & Wellness

Faster Recovery

Reduced Inflammation

Re:Cell Treatment Protocol

Advanced Cellular Regeneration Therapy

Step 1

Pre-Treatment Assessment (D-3)

Comprehensive laboratory evaluation, including complete blood panel, CEA, full lipid profile, urea, creatinine, and HbA1c. Results must be submitted to the clinic no later than 1-3 days prior to treatment.

Step 2

Blood Collection & Vitamin Infusion (D-Day)

50-100 cc of blood is collected by a physician, followed by a supportive vitamin infusion protocol to optimize cellular readiness.

Step 3

Stem Cell Isolation (D-Day)

The collected blood is processed in a certified sterile laboratory environment. Re:Cell is isolated without genetic modification, preserving biological integrity.

Step 4

Re:Cell Infusion (D+1)

Purified Re:Cell plasma is reintroduced into the body through a controlled intravenous infusion protocol.

Initial responses may begin within 4–6 weeks.
Outcomes vary depending on individual biological condition.

Patients may experience mild adaptive responses such as fatigue, drowsiness, or light muscle discomfort as part of the regenerative process.